PCM
ETNB

Pentwater Capital Management’s 89bio ETNB Stock Holding History

Pentwater Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,000
Closed -$32K – 161
2022
Q2 		$32K Buy
+10,000
New +$30.2K ﹤0.01% 175

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pentwater Capital Management's ETNB Position: Q4 2025 in Review

Pentwater Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 11,750,000 shares — an estimated $173M sold.

Pentwater Capital Management first reported a position in ETNB in Q3 2020 and held it in 12 quarters. The position peaked at $173M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Pentwater Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Pentwater Capital Management sold 11,750,000 89bio shares in Q4 2025, an estimated $173M.
  • Pentwater Capital Management first reported a position in 89bio in Q3 2020 and held it in 12 quarters.
  • Pentwater Capital Management's 89bio position peaked at $173M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Pentwater Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.